RU2003106573A - TEST STRIPS FOR DETERMINING THE AVAILABILITY OF THE REDUCING CO-FACTOR IN THE SAMPLE AND WAYS OF THEIR APPLICATION - Google Patents

TEST STRIPS FOR DETERMINING THE AVAILABILITY OF THE REDUCING CO-FACTOR IN THE SAMPLE AND WAYS OF THEIR APPLICATION

Info

Publication number
RU2003106573A
RU2003106573A RU2003106573/13A RU2003106573A RU2003106573A RU 2003106573 A RU2003106573 A RU 2003106573A RU 2003106573/13 A RU2003106573/13 A RU 2003106573/13A RU 2003106573 A RU2003106573 A RU 2003106573A RU 2003106573 A RU2003106573 A RU 2003106573A
Authority
RU
Russia
Prior art keywords
specified
analyte
sample
composition
substrate
Prior art date
Application number
RU2003106573/13A
Other languages
Russian (ru)
Other versions
RU2288273C2 (en
Inventor
Тианмей ОУЯНГ
Йеунг Сиу Ю
Original Assignee
Лайфскен, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/659,938 external-priority patent/US6420128B1/en
Application filed by Лайфскен, Инк. filed Critical Лайфскен, Инк.
Publication of RU2003106573A publication Critical patent/RU2003106573A/en
Application granted granted Critical
Publication of RU2288273C2 publication Critical patent/RU2288273C2/en

Links

Claims (10)

1. Композиция ингредиентов, включающая положительно заряженную подложку и по крайней мере одну растворимую в воде соль тетразолия на по крайней мере одной поверхности указанной положительно заряженной подложки.1. The composition of the ingredients, including a positively charged substrate and at least one water-soluble tetrazolium salt on at least one surface of the specified positively charged substrate. 2. Композиция по п.1, в которой указанная положительно заряженная подложка является адсорбирующей подложкой.2. The composition according to claim 1, in which the specified positively charged substrate is an absorbent substrate. 3. Композиция по п.1, в которой указанная положительно заряженная подложка является не адсорбирующей подложкой.3. The composition according to claim 1, in which the specified positively charged substrate is a non-absorbent substrate. 4. Композиция по любому из пп.1, 2 или 3, в которой указанная растворимая в воде соль тетразолия является частью окисляющей аналит, генерирующей сигнал системы.4. The composition according to any one of claims 1, 2 or 3, wherein said water-soluble tetrazolium salt is part of an oxidizing analyte generating a signal system. 5. Композиция по п.4, в которой указанная окисляющая аналит, генерирующая сигнал система, присутствует как реагентная композиция.5. The composition of claim 4, wherein said oxidizing analyte, a signal generating system, is present as a reagent composition. 6. Реагентная тест-полоска, включающая композицию по любому из пп.1-5.6. Reagent test strip comprising a composition according to any one of claims 1 to 5. 7. Система для обнаружения наличия или определения концентрации аналита, включающая (а) реагентную тест-полоску по п.6 и (б) автоматический инструмент.7. A system for detecting the presence or determination of analyte concentration, comprising (a) a reagent test strip according to claim 6 and (b) an automatic instrument. 8. Способ обнаружения наличия или определения концентрации аналита в образце, где указанный способ включает (а) нанесение указанного физиологического образца на реагентную тест-полоску по п.6, в которой несмываемое пятно, содержащее указанное соединение формазана, образуется на указанной подложке, (б) обнаружение указанного несмываемого пятна и (в) соотнесение указанного обнаруженного несмываемого пятна с наличием или концентрацией указанного аналита в указанном физиологическом образце.8. A method for detecting the presence or determination of analyte concentration in a sample, where the specified method includes (a) applying the specified physiological sample to the reagent test strip according to claim 6, in which an indelible stain containing the specified formazan compound is formed on the specified substrate, (b ) detecting said indelible spot; and (c) correlating said detected indelible spot with the presence or concentration of said analyte in said physiological sample. 9. Набор для применения при определении концентрации аналита в физиологическом образце, где указанный набор включает (а) реагентную тест-полоску по п.6 и (б) по крайней мере, один компонент из (i) средства для получения указанного физиологического образца и (ii) стандартного препарата аналита.9. A kit for use in determining the concentration of analyte in a physiological sample, where the specified kit includes (a) the reagent test strip according to claim 6 and (b) at least one component from (i) means for obtaining the specified physiological sample and ( ii) a standard analyte preparation. 10. Набор по п.9, в котором указанный набор включает средство для получения указанного физиологического образца и стандартный препарат аналита.10. The kit according to claim 9, wherein said kit includes a means for producing said physiological sample and a standard analyte preparation.
RU2003106573/13A 2000-09-12 2001-09-07 Composition of reagents, reagent test-band, system, method and set for detecting or assay of analyte presence in physiological sample RU2288273C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/659,938 2000-09-12
US09/659,938 US6420128B1 (en) 2000-09-12 2000-09-12 Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same

Publications (2)

Publication Number Publication Date
RU2003106573A true RU2003106573A (en) 2004-08-20
RU2288273C2 RU2288273C2 (en) 2006-11-27

Family

ID=24647453

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003106573/13A RU2288273C2 (en) 2000-09-12 2001-09-07 Composition of reagents, reagent test-band, system, method and set for detecting or assay of analyte presence in physiological sample

Country Status (21)

Country Link
US (2) US6420128B1 (en)
EP (1) EP1317563B1 (en)
JP (1) JP2004509618A (en)
KR (1) KR20030065475A (en)
CN (1) CN1561397A (en)
AR (1) AR030650A1 (en)
AT (1) ATE310832T1 (en)
AU (1) AU8893501A (en)
CA (1) CA2422010A1 (en)
CZ (1) CZ2003705A3 (en)
DE (1) DE60115261T2 (en)
DK (1) DK1317563T3 (en)
ES (1) ES2250472T3 (en)
HK (1) HK1053856A1 (en)
IL (1) IL154713A0 (en)
MX (1) MXPA03002078A (en)
MY (1) MY119106A (en)
NO (1) NO20031116L (en)
PL (1) PL363222A1 (en)
RU (1) RU2288273C2 (en)
WO (1) WO2002022855A2 (en)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US7640083B2 (en) 2002-11-22 2009-12-29 Monroe David A Record and playback system for aircraft
US6656697B1 (en) * 1998-09-28 2003-12-02 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
US6420128B1 (en) * 2000-09-12 2002-07-16 Lifescan, Inc. Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
AU2002315177A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
DE60238119D1 (en) 2001-06-12 2010-12-09 Pelikan Technologies Inc ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE
EP1404235A4 (en) 2001-06-12 2008-08-20 Pelikan Technologies Inc Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US6586199B2 (en) * 2001-11-20 2003-07-01 Lifescan, Inc. Stabilized tetrazolium reagent compositions and methods for using the same
US20030119203A1 (en) * 2001-12-24 2003-06-26 Kimberly-Clark Worldwide, Inc. Lateral flow assay devices and methods for conducting assays
US6837171B1 (en) 2002-04-29 2005-01-04 Palmer/Snyder Furniture Company Lightweight table with unitized table top
US6762035B1 (en) * 2002-02-04 2004-07-13 Surendra K. Gupta Method and test strips for the measurement of fat loss during weight loss programs
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US6847451B2 (en) * 2002-05-01 2005-01-25 Lifescan, Inc. Apparatuses and methods for analyte concentration determination
US7244394B2 (en) * 2002-10-03 2007-07-17 Novartis Ag Methods and kits for assays of analytes of interest in tears
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US20040214345A1 (en) * 2003-04-23 2004-10-28 Matzinger David P. Ambidextrous capillary-filled test strip
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
ES2675787T3 (en) 2003-06-20 2018-07-12 F. Hoffmann-La Roche Ag Method and reagent to produce narrow and homogeneous test strips
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US7943395B2 (en) 2003-11-21 2011-05-17 Kimberly-Clark Worldwide, Inc. Extension of the dynamic detection range of assay devices
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US8696880B2 (en) 2004-02-06 2014-04-15 Bayer Healthcare Llc Oxidizable species as an internal reference for biosensors and method of use
EP1751546A2 (en) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Printable hydrogel for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
MX2008000836A (en) 2005-07-20 2008-03-26 Bayer Healthcare Llc Gated amperometry.
KR101477948B1 (en) 2005-09-30 2014-12-30 바이엘 헬스케어 엘엘씨 Gated voltammetry analysis duration determination
US20080003629A1 (en) * 2006-04-07 2008-01-03 Morris Shayne K Device and method for detection of vitamins and nutritional minerals
EP1936362B1 (en) * 2006-12-20 2020-03-18 Roche Diabetes Care GmbH Test element with referencing
CA2701170A1 (en) 2007-09-29 2009-08-27 Timothy James Williams Composition and method to modify sperm function and increase male gender ratio in mammals
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US8008068B2 (en) * 2008-02-29 2011-08-30 Light Pointe Medical, Inc. Nonhemolytic optical sensor with enhanced reflectance
US20090219509A1 (en) * 2008-02-29 2009-09-03 Hiroshi Nomura Optical sensor with enhanced reflectance
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
BR112014001544B1 (en) * 2011-07-22 2020-10-06 Access Bio, Inc TAPE WITH INDIVIDUAL PILLOW FOR AN IMPROVED SIDE FLOW TEST AND CHROMATOGRAPHIC TEST
KR20180004027A (en) * 2016-06-30 2018-01-10 휴마시스 주식회사 Analytical kit for enzyme activity
KR101974645B1 (en) * 2016-12-02 2019-05-02 에스디 바이오센서 주식회사 A strip for simultaneously measuring total-hemoglobin and glucose-6-phosphate dehydrogenase, a preparing method thereof, and a use of the same
CN109574296B (en) * 2018-11-27 2021-05-07 合肥工业大学 Method for recovering protein from crab meat protein-containing wastewater

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3791988A (en) * 1972-03-23 1974-02-12 Hoffmann La Roche Diagnostic test for glucose
CS164231B2 (en) * 1972-09-28 1975-11-07
FR2258235B1 (en) * 1974-01-21 1981-02-06 Voest Ag
US4254222A (en) * 1978-07-19 1981-03-03 Owen Oliver E Semi-quantitative assay of lactic acid and β-hydroxy butyrate
JPS6024199A (en) * 1983-07-18 1985-02-06 Nippon Chemiphar Co Ltd Determination of substance relating to disease
US5032506A (en) * 1986-12-16 1991-07-16 Enzymatics, Inc. Color control system
DE3826922A1 (en) * 1988-08-09 1990-02-22 Boehringer Mannheim Gmbh PROCESS FOR THE COLOR-RIMETRIC DETERMINATION OF AN ANALYTE BY ENZYMATIC OXIDATION
US5340722A (en) * 1988-08-24 1994-08-23 Avl Medical Instruments Ag Method for the determination of the concentration of an enzyme substrate and a sensor for carrying out the method
SE466158B (en) * 1989-04-25 1992-01-07 Migrata Uk Ltd METHOD OF ANALYSIS FOR GLUCOSE DETERMINATION IN WHOLE BLOOD
EP0654079B1 (en) 1992-07-02 2000-03-22 Roche Diagnostics Corporation A reagent stabilized by bivalent metal salts
EP0648278B1 (en) 1992-07-02 1999-12-08 Roche Diagnostics Corporation Stabilizing tetrazolium salts in a reagent
DE4311464A1 (en) * 1993-04-08 1994-10-13 Boehringer Mannheim Gmbh Method for the colorimetric determination of an analyte with a PQQ-dependent dehydrogenase
JP2757348B2 (en) 1996-04-18 1998-05-25 株式会社同仁化学研究所 New water-soluble tetrazolium salt compound
US5902731A (en) * 1998-09-28 1999-05-11 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US6656697B1 (en) * 1998-09-28 2003-12-02 Lifescan, Inc. Diagnostics based on tetrazolium compounds
US6420128B1 (en) * 2000-09-12 2002-07-16 Lifescan, Inc. Test strips for detecting the presence of a reduced cofactor in a sample and method for using the same

Similar Documents

Publication Publication Date Title
RU2003106573A (en) TEST STRIPS FOR DETERMINING THE AVAILABILITY OF THE REDUCING CO-FACTOR IN THE SAMPLE AND WAYS OF THEIR APPLICATION
RU2002131152A (en) COMPOSITIONS OF STABILIZED TETRAZOLIUM REAGENT AND WAYS OF THEIR APPLICATION
RU2002131153A (en) COMPOSITIONS OF STABILIZED TETRAZOLI-PHENAZINE REAGENT AND METHODS OF APPLICATION
JP2004509618A5 (en)
EP0475692B1 (en) Visual blood glucose concentration test strip
US3552928A (en) Whole blood separation means and test system using same
RU2002113055A (en) TEST STRIP WITH REAGENT FOR DETERMINING THE CONTENT OF ANALYZED SUBSTANCE
US6762062B2 (en) Method of determining cholesterol and sensor applicable to the same
PT1269173E (en) QUICK RESPONSE GLUCOSE SENSOR
ATE80736T1 (en) TRANSPARENT TEST STRIP SYSTEM.
RU2003100531A (en) COMPOSITIONS CONTAINING A DYE BASED ON UREA DERIVATIVES FOR THE DETECTION OF ANALYTES, AND METHODS FOR USING THEM
CA2322858A1 (en) Detection of analytes by fluorescent lanthanide chelates
WO2001038873A3 (en) Devices and methods for detecting analytes using electrosensor having capture reagent
JP2004518128A5 (en)
ATE219245T1 (en) BIOSENSOR, IONTOPHORETIC SAMPLING SYSTEM, AND METHOD FOR USE THEREOF
HU908021D0 (en) Application of hardly dissoluble salts of heteropolyacid for determining analyt, the process of analysis and preparative serving for it
FI80343C (en) TESTANORDNING.
AR030650A1 (en) TEST STRIPS TO DETECT THE PRESENCE OF A REDUCED COFACTOR IN A SAMPLE AND METHODS TO USE THEM
DE68908900D1 (en) DETECTION AND DETERMINATION OF THE AMOUNT OF RNS AND DNA.
CA2121361A1 (en) Apparatus and Method of Saliva Collection and Verification for Dried Saliva Spot Drug and HIV Antibody Testing
KR910006727A (en) Hydrophilic laminated porous membrane and manufacturing method thereof
CA2283154A1 (en) Method and apparatus for measurement of blood substitutes
ES509142A0 (en) PROCEDURE TO DETERMINE THE PRESENCE OF AN ANALYTE IN A SAMPLE SUSPECTED TO CONTAIN IT.
ATE354088T1 (en) METHOD FOR QUANTIFYING OXIDIZED GLUTATHIONE
ES540545A0 (en) A METHOD FOR THE PREPARATION OF A TEST INSTRUMENT TO DETERMINE THE PRESENCE OF AN ION IN A WATER TEST SAMPLE